Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis

Author:

Zhao Mingyue,Gillani Ali Hassan,Ji Duan,Feng Zhitong,Fang Yu,Yang Caijun

Abstract

Objectives: The primary objective of the study was to assess the impact of the Low-Price Medicine Policy (LPMP) on the supply of low-price medicines (LPMs) in China. The secondary objective of the study was to describe the supply situation of LPMs from 2005 to 2018.Methods: The LPMP was launched in the third quarter of 2014 (2014Q3). An interrupted time series analysis was used to evaluate the impact of LPMP on the supply of LPMs in China. Ordinary least squares and Poisson regression models were utilized to estimate the effect of LPMP on LPMs’ supply growth rate and the number of supplied LPMs. All the LPMs were divided into two subgroups: intermittent supply and continuous supply. The trend and level changes of the quarterly average growth rate and number of quarterly supplies for different LPM groups were analyzed from 2005 to 2018.Findings: For the quarterly average growth rate, before the intervention, a significant increasing trend was observed in the total group and the continuous supply subgroup; after the introduction of LPMP, the increasing trend was ceased and a significant decrease in the trend and level was noted for both the total group (trend coefficient: β3= −0.0132, p < 0.01; level coefficient: β2 = −0.1510, p < 0.05) and the continuous supply subgroup (trend coefficient: β3 = −0.0133, p < 0.01; level coefficient: β2 = −0.1520, p < 0.05); whereas it had no significant effect for intermittent supply subgroup. For the number of quarterly supplies, after the intervention of LPMP, decline of the supply number was observed (trend coefficient: β3 = −0.0027, p < 0.001; level coefficient: β2 = −0.0584, p < 0.001); whereas the LPMP was associated with an upward trend and level (trend coefficient: β3 = 0.0715, p < 0.001; level coefficient: β2 = 0.174) for the intermittent supply subgroup.Conclusion: For most of the LPMs, LPMP did not meet the goal of stimulating LPM production. However, for severely shortage medicines (the intermittent supply subgroup), the effect of LPMP was positive. Comprehensive policies rather than just deregulating medicine price should be introduced to alleviate the situation of medicine shortage in China.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Natural Science Foundation of Shaanxi Province

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. On current situation, influence and solution to drug shortage of primary medical institutions in Shaanxi province;Cai;Chin. Pharm. Aff.,2017

2. Europe urged to take action on drug shortages;Casassus;Lancet,2015

3. Many of essential medicines are shortage in hospitals in China; c20202011

4. Policy efforts to find a way to solve the problem of medicine shortage; c20202018

5. The price of calcium gluconate rises again, six provinces’ market are in a hurry; c20182018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3